Integration of High-Throughput Drug Screening on Patient Derived Organoids into Pediatric Precision Medicine Programs: The Future is Now

Langenberg K.; Kholosy W.; Schild L.; Breunis W.; Koopmans B.; Koster J.; Goemans B.; Zwaan C. M.; Molenaar J.; Dolman E.

首页> 外文期刊>Pediatric blood & cancer >Integration of High-Throughput Drug Screening on Patient Derived Organoids into Pediatric Precision Medicine Programs: The Future is Now

【24h】

Integration of High-Throughput Drug Screening on Patient Derived Organoids into Pediatric Precision Medicine Programs: The Future is Now

机译：高通量药物筛查对患者源性有机体筛毒到儿科精密医学计划的整合：未来现在

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2019年第s4期|共1页
作者
Langenberg K.; Kholosy W.; Schild L.; Breunis W.; Koopmans B.; Koster J.; Goemans B.; Zwaan C. M.; Molenaar J.; Dolman E.;
展开▼
作者单位

Princess Maxima Ctr Pediat Oncol Translat Res Utrecht Netherlands;

Princess Maxima Ctr Pediat Oncol Translat Res Utrecht Netherlands;

Princess Maxima Ctr Pediat Oncol Translat Res Utrecht Netherlands;

Princess Maxima Ctr Pediat Oncol Translat Res Utrecht Netherlands;

Princess Maxima Ctr Pediat Oncol Translat Res Utrecht Netherlands;

Amsterdam Med Ctr Dept Oncogen Grp Leader Bioinformat Amsterdam Netherlands;

Princess Maxima Ctr Pediat Oncol Hematol Oncol Utrecht Netherlands;

Princess Maxima Ctr Pediat Oncol Early Phase Clin Trials Utrecht Netherlands;

Princess Maxima Ctr Pediat Oncol Translat Res Utrecht Netherlands;

Princess Maxima Ctr Pediat Oncol Translat Res Utrecht Netherlands;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
专利

1. Integration of High-Throughput Drug Screening on Patient Derived Organoids into Pediatric Precision Medicine Programs: The Future is Now [J] . Langenberg K., Kholosy W., Schild L., Pediatric blood & cancer . 2019,第S4期

机译：高通量药物筛查对患者源性有机体筛毒到儿科精密医学计划的整合：未来现在
2. High-Throughput Screening of Patient-Derived Cultures Reveals Potential for Precision Medicine in Glioblastoma [J] . Quartararo Christine E., Reznik Eduard, deCarvalho Ana C., ACS medicinal chemistry letters . 2015,第8期

机译：高通量筛选患者源性培养物揭示了胶质母细胞瘤中精准医学的潜力
3. Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer [J] . Tsoli Maria, Wadham Carol, Pinese Mark, Cancer biology & therapy . 2018,第10a12期

机译：基因组学，高通量药物筛选和个性化异种移植模型的整合为高风险儿科癌症的新型精密医学范式
4. The Developing Status of High-Throughput Drug Screening Microfluidic Chip by FRET on Medicine [C] . Xin-Yu Zhang, Qiu-Hong Huang, Mei Yang, China Functional Material Technology and Industry Forum . 2018

机译：医学案中肌肉卷尺的高通量药物筛选微流体芯片的发展状况
5. Computer-Assisted Drug Discovery Part I: Design, Development, Validation and Application of FRESH, a Novel In-Silico High-throughput Screening Program Part II: Monocarbonyl Curcumin Analogues: Heterocyclic Pleiotropic Kinase Inhibitors that Mediate Anticancer Properties Part III: Development of 2nd Generation NAMFIS Software Program [D] . Shi, Qi 2014

机译：计算机辅助药物发现，第一部分：FRESH的设计，开发，验证和应用，一种新型的硅中高通量筛选程序第二部分：单羰基姜黄素类似物：介导抗癌特性的杂环多效性激酶抑制剂第三部分：第二代药物的开发NAMFIS软件程序
6. Integration of genomics high throughput drug screening and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer [O] . Maria Tsoli, Carol Wadham, Mark Pinese, 2018

机译：整合基因组学高通量药物筛选和个性化异种移植模型将其作为高危儿科癌症的新型精确医学范例
7. Patient-derived organoid analysis of drug resistance in precision medicine: is there a value? [O] . Amira Abugomaa, Mohamed Elbadawy 2020

机译：患者衍生的有机体含量分析精密药物耐药性：有价值吗？

Integration of High-Throughput Drug Screening on Patient Derived Organoids into Pediatric Precision Medicine Programs: The Future is Now

著录项

相似文献

相关主题

期刊订阅